Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Enzon Pharmaceuticals Inc. (ENZN) had Income from Continuous Operations of $-0.99M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-1.52M |
|
-- |
|
-- |
|
$1.53M |
|
$-1.53M |
|
$0.50M |
|
$-1.03M |
|
$-1.03M |
|
$-0.99M |
|
|
Income from Continuous Operations |
$-0.99M |
$-0.99M |
|
$-0.99M |
|
$-1.53M |
|
$-1.53M |
|
74.22M |
|
74.22M |
|
$-0.02 |
|
$-0.02 |
|
| Balance Sheet Financials | |
$44.74M |
|
-- |
|
$0.04M |
|
$44.78M |
|
$0.80M |
|
-- |
|
-- |
|
$0.80M |
|
$0.43M |
|
$43.98M |
|
$43.98M |
|
74.21M |
|
| Cash Flow Statement Financials | |
$-1.29M |
|
-- |
|
$-1.27M |
|
$46.86M |
|
$44.29M |
|
$-2.56M |
|
-- |
|
-- |
|
$-1.27M |
|
| Fundamental Metrics & Ratios | |
55.71 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.29M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-229.17% |
|
-2.25% |
|
-2.21% |
|
-2.25% |
|
$0.59 |
|
$-0.02 |
|
$-0.02 |
|